Archive | ARTES Biotechnology GmbH

Home / Archive

Cellumed and ARTES Sign Development and License Agreement

Cellumed and ARTES Sign Development and License Agreement

Thursday 14th October 2021

By ARTES Biotechnology… Learn More >

50351ARTES Biotechnology GmbH – Recombinant Protein Production

ARTES Biotechnology GmbH – Recombinant Protein Production

Tuesday 28th September 2021

By ARTES Biotechnology… Learn More >

50261ARTES Biotechnology Protein Expression and Process Development in Yeast

ARTES Biotechnology Protein Expression and Process Development in Yeast

Friday 10th September 2021

By ARTES Biotechnology… Learn More >

“Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations

Thursday 14th January 2021

By ARTES Biotechnology… Learn More >

ARTES is convinced: defeating SARS COVID-19 will require different vaccines

ARTES is convinced: defeating SARS COVID-19 will require different vaccines

Friday 11th September 2020

By ARTES Biotechnology… Learn More >

Worldwide, researchers work on a coronavirus vaccine

Worldwide, researchers work on a coronavirus vaccine

Tuesday 16th June 2020

By ARTES Biotechnology… Learn More >

ARTES joins global CV-19 combat with VLP vaccine candidates

Monday 27th April 2020

By ARTES Biotechnology… Learn More >

France renews CIR tax credits for ARTES R&D services

Thursday 2nd April 2020

By ARTES Biotechnology… Learn More >

ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris

Monday 9th March 2020

By ARTES Biotechnology… Learn More >

ARTES VLP-based vaccine development

Thursday 19th September 2019

By ARTES Biotechnology… Learn More >

Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute

Friday 13th September 2019

By ARTES Biotechnology… Learn More >

ARTES presenting new development offer at BIOEurope Spring in Vienna

Tuesday 12th March 2019

By ARTES Biotechnology… Learn More >